Arcturus Therapeutics initiates phase 3b study of ARCT-154 vaccines in Vietnam
October 13, 2021 | 15:18
Arcturus Therapeutics Holdings Inc. has got the nod from the Ministry of Health to start phase 3b study of ARCT-154 self-replicating RNA vaccine in Vietnam.
Clinical trial of ARCT-154 COVID-19 vaccine begins in Vietnam
August 16, 2021 | 10:43
The Hanoi Medical University on August 15 began the human clinical trial of the ARCT-154 vaccine against COVID-19, using mRNA technology from the US.
Mobile Version